Product nameAnti-TSR1 antibody
See all TSR1 primary antibodies
DescriptionRabbit polyclonal to TSR1
Tested applicationsSuitable for: WBmore details
Unsuitable for: IP
Species reactivityReacts with: Mouse, Human
Predicted to work with: Orangutan
Synthetic peptide within Human TSR1 aa 475-525. The exact sequence is proprietary.
Database link: Q2NL82
- WB: HeLa, HEK-293T, Jurkat, TCMK-1 and NIH/3T3 cell lysates.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: Tris citrate/phosphate
pH 7 to 8
Concentration information loading...
PurityImmunogen affinity purified
Purification notesAntibody was affinity purified using an epitope specific to TSR1 immobilized on solid support.
Our Abpromise guarantee covers the use of ab241613 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 92 kDa.|
RelevanceTSR1 belongs to the BMS1/TSR1 family and TSR1 subfamily. TSR1 is required during maturation of the 40S ribosomal subunit in the nucleolus.
Cellular localizationNucleus › nucleolus
- AU040765 antibody
- AW550801 antibody
- FLJ10534 antibody
All lanes : Anti-TSR1 antibody (ab241613) at 0.4 µg/ml
Lane 1 : HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate
Lane 2 : HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cell lysate
Lane 3 : Jurkat (human T cell leukemia cell line from peripheral blood) cell lysate
Lane 4 : TCMK-1 (mouse kidney epithelial cell line) cell lysate
Lane 5 : NIH/3T3 (mouse embryo fibroblast cell line) cell lysate
Lysates/proteins at 50 µg per lane.
Developed using the ECL technique.
Predicted band size: 92 kDa
Exposure time: 30 seconds
Lysates prepared in NETN buffer.
ab241613 has not yet been referenced specifically in any publications.